Core Laboratories NV (CLB)
Official siteENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE
Market Cap: $417.45M
Last updated: Nov 17, 2026 at 11:04 AM ET
Core Laboratories NV (CLB) P/E Ratio & Valuation History
Core Laboratories NV (CLB) trades at 15.7x trailing earnings and 0.8x sales. Its P/E of 15.7x is below its 5-year median of 23.2x. Its forward P/E is 19.8x. The median P/E across 8 similar companies is 18.2x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 20.7% lower over the next year.
| Multiple | Value |
|---|---|
| P/E (trailing) | 15.7x |
| Forward P/E | 19.8x |
| Price to sales | 0.8x |
| Price to book | 1.4x |
| EV/EBITDA | 9.2x |
| PEG | 1.7 |
| FCF yield | -0.1% |
Historical Medians
Against its 10-year medians, its P/E is 46.6% below 29.4x, its P/S is 65.2% below 2.3x and its P/B is 82.5% below 8.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 15.7x | 23.2x | 29.4x |
| P/S | 0.8x | 1.7x | 2.3x |
| P/B | 1.4x | 3.7x | 8.0x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 19.7x in 2024 to 79.5x in 2016.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $16.03 | 21.1x | 1.4x | 2.8x |
| 2024 | $17.31 | 19.7x | 1.6x | 3.3x |
| 2023 | $17.66 | 21.8x | 1.6x | 3.7x |
| 2022 | $20.27 | 34.9x | 1.9x | 5.2x |
| 2021 | $22.31 | 31.4x | 2.2x | 6.7x |
| 2020 | $26.51 | 33.6x | 2.4x | 16.7x |
| 2019 | $37.67 | 21.2x | 2.5x | 9.5x |
| 2018 | $59.66 | 26.2x | 3.8x | 16.5x |
| 2017 | $109.55 | 54.8x | 7.4x | 32.6x |
| 2016 | $120.04 | 79.5x | 8.8x | 34.3x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CLB
What is CLB's forward P/E ratio?
Core Laboratories NV has a forward P/E ratio of 19.8x.
Is CLB stock overvalued?
GNG's valuation label for CLB is Undervalued. Its P/E of 15.7x compares with a median of 18.2x across 8 similar companies.
What is CLB's price to sales ratio?
Core Laboratories NV has a price to sales ratio of 0.8x.
What is Core Laboratories NV's average P/E ratio over 5 years?
Core Laboratories NV's median P/E over the last 5 years is 23.2x, from 60 month-end values through Oct 2026.
What is CLB's PEG ratio?
Core Laboratories NV has a PEG ratio of 1.7.
CLB pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors